MELBOURNE, Australia, July 21, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (GENE) (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness and serious disease, ...
MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven ...
CHARLOTTE, N.C., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious ...
Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has announced an extension to the voluntary suspension of its securities as it finalizes funding agreements crucial ...
Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has announced an extension for its Entitlement Offer Prospectus until December 2, 2024, providing investors more time ...
An update from Genetic Technologies ( (AU:GTG)) is now available. Genetic Technologies Limited has announced that director Anthony Hartman has ceased to be a director of the company as of 9 September ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results